Clinical Trial Update: Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating retinal stem and progenitor cell therapy for age-related macular degeneration is in Phase 1/Phase 2, with no current status reported…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• retinal stem and progenitor cells

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN